Veradigm (NASDAQ:MDRX) Shares Down 8% – Should You Sell?

Veradigm Inc. (NASDAQ:MDRX) shares traded down 8% during trading on Monday . The company traded as low as $4.53 and last traded at $4.60. 1,056 shares were traded during trading, a decline of 99% from the average session volume of 158,328 shares. The stock had previously closed at $5.00.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of Veradigm to a “hold” rating in a research report on Saturday, March 7th.

Veradigm Stock Performance

The company has a 50 day moving average of $4.77 and a 200 day moving average of $4.67. The firm has a market cap of $621.28 million, a P/E ratio of 23.25 and a beta of 0.55.

About Veradigm

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.